Literature DB >> 167434

Adenosine inhibition of lymphocyte-mediated cytolysis: possible role of cyclic adenosine monophosphate.

G Wolberg, T P Zimmerman, K Hiemstra, M Winston, L C Chu.   

Abstract

The in vitro destruction of tumor cells by specifically sensitized mouse lymphocytes was inhibited by adenosine; this inhibition was markedly potentiated by the presence of an inhibitor of adenosine deaminase. The inhibition of cytolysis by adenosine was accompanied by a rapid elevation in lymphocytic adenosine 3',5'-monophosphate (cyclic AMP) concentrations. Both the inhibition of cytolysis and the elevation of cyclic AMP were reversed by prolonged incubation of the lymphocytes in the presence of adenosine or, more rapidly, by removal of the adenosine. Low concentrations of adenosine also caused an elevation of cyclic AMP in human lymphocytes, and this effect of adenosine may contribute to the lack of immune response associated with adenosine deaminase deficiency.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167434     DOI: 10.1126/science.167434

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  48 in total

Review 1.  A(2A) adenosine receptors in human peripheral blood cells.

Authors:  S Gessi; K Varani; S Merighi; E Ongini; P A Borea
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

Review 2.  Individuality in disease and therapy.

Authors:  B Cinader
Journal:  Can Med Assoc J       Date:  1975-07-12       Impact factor: 8.262

Review 3.  Regulation of adenylate cyclase by adenosine.

Authors:  J N Fain; C C Malbon
Journal:  Mol Cell Biochem       Date:  1979-06-15       Impact factor: 3.396

4.  Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).

Authors:  D A Carson; J Kaye; J E Seegmiller
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

5.  3-Deazaadenosine analogues inhibit the production of tumour necrosis factor-alpha in RAW264.7 cells stimulated with lipopolysaccharide.

Authors:  S Y Jeong; J H Lee; H S Kim; S H Hong; C H Cheong; I K Kim
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

6.  Inhibition of lymphocyte-mediated cytolysis by 3-deazaadenosine: evidence for a methylation reaction essential to cytolysis.

Authors:  T P Zimmerman; G Wolberg; G S Duncan
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

7.  Purine nucleoside metabolism in the erythrocytes of patients with adenosine deaminase deficiency and severe combined immunodeficiency.

Authors:  R P Agarwal; G W Crabtree; R E Parks; J A Nelson; R Keightley; R Parkman; F S Rosen; R C Stern; S H Polmar
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

Review 8.  Purinergic signaling in inflammatory cells: P2 receptor expression, functional effects, and modulation of inflammatory responses.

Authors:  Fenila Jacob; Claudina Pérez Novo; Claus Bachert; Koen Van Crombruggen
Journal:  Purinergic Signal       Date:  2013-02-13       Impact factor: 3.765

9.  Two distinct adenosine-sensitive sites on adenylate cyclase.

Authors:  C Londos; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Selective toxicity of purine deoxynucleosides for human lymphocyte growth and function.

Authors:  E W Gelfand; J J Lee; H M Dosch
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.